SLE patients are not immune to covid-19: importance of sending the right message across

Goyal, Mohit

doi:10.1136/annrheumdis-2020-217658

Cited by 14 publications

(19 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In our opinion, rheumatic disease patients are not immune to SARS-CoV-2 infection, which is coincide with Sawalha AH and Goyal M et al's views [7,8]. This opinion has been reinforced by the data from The COVID-19 Global Rheumatology Alliance Global Registry [9], which showed that 600 patients with rheumatic disease who have been diagnosed with COVID-19, including 144 RA patients and 72 SLE patients.…”

Section: Evidences For Sars-cov-2 Susceptibility In Patients With Rhesupporting

confidence: 74%

The correlation between SARS-CoV-2 infection and rheumatic disease

Gao

Wang

Lin

et al. 2020

Autoimmunity Reviews

View full text Add to dashboard Cite

show abstract

Section: Evidences For Sars-cov-2 Susceptibility In Patients With Rhesupporting

confidence: 74%

The correlation between SARS-CoV-2 infection and rheumatic disease

Gao

Wang

Lin

et al. 2020

Autoimmunity Reviews

View full text Add to dashboard Cite

show abstract

“…As Nikipharou et al [20] already pointed out, social media platforms provide novel ways for opinion sharing, learning and development, which is especially important in times of uncertainties during a pandemic. Notably, social media can effectively increase the impact of scientific [23][24][25][26][27] publications which might be of interest to researchers and scientific journals alike [21]. Social media can direct attention and increase participation for digital crowdsourcing projects, such as the COVID-19 Global Rheumatology Alliance registries or healthcare policy projects.…”

Section: Discussionmentioning

confidence: 99%

#Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic

2020

View full text Add to dashboard Cite

Social media services, such as Twitter, offer great potential for a better understanding of rheumatic and musculoskeletal disorders (RMDs) and improved care in the field of rheumatology. This study examined the content and stakeholders associated with the Twitter hashtag #Covid4Rheum during the COVID-19 pandemic. The content analysis shows that Twitter connects stakeholders of the rheumatology community on a global level, reaching millions of users. Specifically, the use of hashtags on Twitter assists digital crowdsourcing projects and scientific collaboration, as exemplified by the COVID-19 Global Rheumatology Alliance registry. Moreover, Twitter facilitates the distribution of scientific content, such as guidelines or publications. Finally, digital data mining enables the identification of hot topics within the field of rheumatology.

show abstract

“…In the first period of the COVID-19 pandemic, treatment with hydroxychloroquine (HCQ) was suggested as an inhibitor of SARS-CoV-2 in vitro, but recent studies involving SLE patients have demonstrated that the doses used in treatment of SLE are not protective against severe COVID-19 infection [5][6][7][8][9][10]. On the other hand glucocorticoids might increase the risk of hospitalisation and a subsequent severe outcome [11,12].…”

Section: Introductionmentioning

confidence: 99%

Incidence of COVID-19 Hospitalisation in Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study from Denmark

Cordtz

Kristensen

Dalgaard

et al. 2021

JCM

View full text Add to dashboard Cite

Background: Patients with systemic lupus erythematosus (SLE) have an increased risk of infections due to impaired immune functions, disease activity, and treatment. This study investigated the impact of having SLE on the incidence of hospitalisation with COVID-19 infection. Methods: This was a nationwide cohort study from Denmark between 1 March 2020 to 2 February 2021, based on the linkage of several nationwide registers. The adjusted incidence of COVID-19 hospitalisation was estimated for patients with SLE compared with the general population in Cox-regression models. Among SLE patients, the hazard ratio (HR) for hospitalisation was analysed as nested case-control study. Results: Sixteen of the 2533 SLE patients were hospitalised with COVID-19 infection. The age-sex adjusted rate per 1000 person years was 6.16 (95% CI 3.76–10.08) in SLE patients, and the corresponding hazard ratio was 2.54 (95% CI 1.55–4.16) compared with the matched general population group after adjustment for comorbidities. Among SLE patients, hydroxychloroquine treatment was associated with a HR for hospitalisation of 0.61 (95% CI 0.19–1.88), and 1.06 (95% CI 0.3–3.72) for glucocorticoid treatment. Conclusion: Patients with SLE were at increased risk of hospitalisation with COVID-19.

show abstract

SLE patients are not immune to covid-19: importance of sending the right message across

Abstract: Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

Cited by 14 publications

References 3 publications

The correlation between SARS-CoV-2 infection and rheumatic disease

The correlation between SARS-CoV-2 infection and rheumatic disease

#Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic

Incidence of COVID-19 Hospitalisation in Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study from Denmark

Contact Info

Product

Resources

About